Biologics in Patients With Psoriasis: Cancer Risks Compared

A Danish registry study finds no substantial differences in the 5-year risk for first cancers between three biologics in patients with psoriasis.
Medscape Medical News

source https://www.medscape.com/viewarticle/biologics-patients-psoriasis-cancer-risks-compared-2025a1000st0?src=rss